In oral squamous cell carcinoma, treatment with NaHS has been shown to facilitate cell cycle progression by downregulating the protein expressions of the DNA repairing RPA70 and tumor suppressor RB1, while upregulating those of the proliferating cell nuclear antigen (PCNA) and CDK4 172. This evidence concerns the gene PCNA and oral cavity squamous cell carcinoma.